INTRODUCTION
Cataract surgery is currently the most common ophthalmic surgical procedure in the world. This procedure involves the extracapsular extraction of the opaque lens fi bers and implantation of an intraocular lens (IOL) which restores good vision. [1] However, posterior capsular opacifi cation (PCO), which is also termed as secondary cataract, is a common long-term complication of modern cataract surgery. [2] create a 2-3 mm diameter opening in the center of the opacifi ed capsule with a minimum number of laser shots. Post capsulotomy, patients were assessed immediately, after 1 hour and 3 hours (hrs) respectively for IOP.
Statistical analysis
The data was analyzed using Statistical Package for Social Sciences. Independent samples "t"-test and analysis of variance has been used to compare the data. Chi-square test has been used to compare the proportions. The confi dence level of the study was kept at 95%, hence a "P" value less than 0.05 is indicated as a statistically signifi cant intergroup diff erence.
RESULTS
Age of patients ranged from 13 to 100 years with a mean age 57.86 ± 14.88 years in Group I and 60.70 ± 11.24 years in Group II. Majority of subjects in both the groups were females and had PCO grades I and II. Mean post-surgery time lag for PCO formation was 3.16 ± 2.14 years in Group I and 3.51 ± 3.31 years in Group II. The two groups were matched statistically for age, gender, PCO grade and mean post-surgery time lag for PCO formation [ Table 1 ].
Before the procedure, mean IOP in Group I was 15.30 ± 2.83 mmHg as compared to 16.15 ± 2.48 mmHg in Group II, thus showing mean IOP in Group II to be signifi cantly higher (P = 0.019). However, immediately after the procedure the mean IOP in Group I was 14.55 ± 2.87 mmHg as compared to 13.16 ± 3.72 mmHg in Group II thus showing mean IOP in Group II to be signifi cantly lower (P = 0.002). One hour and 3 hrs after the procedure too, mean IOP in Group II was signifi cantly lower as compared to that in Group I (P < 0.001) [ Table 2 ].
On evaluating the impact of diff erent demographic, clinical and procedural variables on IOP change, impact of intervention (0.5% Timolol maleate), time which peaks in the fi rst 3 hrs of laser application. [4] The increase in IOP noted in previous literature is 5-10 mmHg which may lead to serious eye damage, especially in patients with advanced glaucoma who have higher frequency of this complication. [5] For preventing the transient rise of IOP there are varied opinions about the use of Timolol maleate eye drops, which is a non-selective ß 1 and ß 2 adrenergic receptor antagonist and has an IOP lowering action by reducing aqueous humor production. [6] Because of the lack of common consensus about the effi cacy and need of pre-capsulotomy use of Timolol maleate in controlling diff erent ranges of raised IOP spikes, this study was undertaken with the aim to evaluate the role and effi cacy of prophylactic use of Timolol maleate (0.5%) eyedrop in preventing rise of IOP post Nd: YAG capsulotomy.
MATERIALS AND METHODS
This was a randomized parallel group study conducted over a period of 18 months from November 2010 to July 2012 at Era's Lucknow medical college and hospital, Lucknow. The study was conducted in 220 eyes which were divided into two Groups (Gp.) with 110 eyes in each group after randomization. Gp. I included eyes in which placebo (artifi cial tear substitute) was instilled before the laser treatment whereas Gp. II included eyes in which Timolol maleate (0.5%) was instilled before the laser treatment. Patients excluded were those already using antiglaucoma medications, having absolute or relative contraindications to YAG capsulotomy (e.g. corneal edema, corneal ulcer, corneal scarring, presence of glass IOL, anterior uveitis, macular edema) and in those where use of Timolol maleate eye drop was contraindicated (e.g. Asthmatic and cardiac patients). Precapsulotomy assessment of patients was done for vision, baseline IOP (by Applanation tonometery), slit-lamp examination for any contraindication for the procedure as well as to grade the PCO (using Madurai Intraocular lens study IV [7, 20] ) 110 eyes in group I were given placebo before capsulotomy while in the rest of 110 eyes comprising group II, 0.5% Timolol maleate eyedrop was instilled pre-casulotomy. Following instillation of eyedrops (Placebo/Timolol) patients were instructed to press over the puncta for 5 minutes and keep the eyes closed. Topical anesthetic 4% Paracaine was instilled and then a wide fi eld spectral Nd.YAG laser contact lens (Abraham's contact lens) was placed over the cornea with viscoelastic substance as coupling agent. The slit-lamp beam was narrowed and obliquely angled (to help reduce miosis). Laser shots with low energy (1 milliJoule) were given initially and gradually increased as per requirement. Aim was to lag since cataract surgery, grade of PCO and amount of total energy required were found to be signifi cantly associated with the change in IOP.
Immediately after the procedure, mean reduction in IOP was 0.75 ± 1.92 mmHg in Group I as compared to 2.98 ± 2.91 in Group II (P < 0.001). At 1 hr after procedure, mean reduction in IOP was 0.11 ± 2.15 mmHg in Group I as compared to 2.69 ± 3.11 mmHg in Group II (P < 0.001). At 3 hrs after procedure interval, mean reduction in IOP was 1.90 ± 2.73 mmHg in Group II as compared to a mean increase in IOP to the tune of 0.31 ± 1.97 mmHg in Group I (P < 0.001) [ Table 3 ].
With increasing grade of PCO reduction in post-procedure IOP was lower and reduction in IOP was maximum in patients requiring <30 mJ of total energy [ Table 4 ].
DISCUSSION
Nd: YAG laser posterior capsulotomy is the treatment of choice for the PCO. This procedure has gained popularity as it is non-invasive, relatively safer, less time consuming and free from infections as compared to needle capsulotomy but has been associated with complications like corneal burns, intra ocular lens pi ing and raised IOP varying from 1.6% [8] to 42.85%. [9] In the present study, the focus was kept on IOP changes following Nd: YAG laser capsulotomy with and without pre-capsulotomy use of Timolol maleate 0.5% eye drops. It has been shown in literature that Timolol maleate 0.5% is a useful intervention to inhibit IOP rise following Nd: YAG laser posterior capsulotomy. [8, 10, 11] In our study no rise in mean IOP was observed in either Gp. I or Gp. II, instead a nominal reduction in mean IOP was observed in both groups I and II (0.75 ± 1.92 and 2.98 ± 2.91 mmHg, respectively). This diff erence was statistically signifi cant. At 3 hrs post-procedure interval, there was a rise in mean IOP in the placebo group (0.31 ± 1.97 mm Hg) whereas mean IOP in the Timolol maleate group was still lower by 1.90 ± 2.73 mm Hg as compared to precapsulotomy IOP which again was signifi cant statistically. Contrary to our study, Cai et al. (2008) [12] observed a mean rise of 0.9 mmHg in the treatment group as compared to 2.1 mmHg in the placebo group and in another previous study by Rakofsky et al. (1997) , [10] 7% of the Timolol group and 36% of the placebo group an IOP [13] and in our study also there was a signifi cant association between the total amount of energy used and change in IOP [ Table 4 ]. In Gp. II, irrespective of total amount of energy delivered, at no post Nd: YAG capsulotomy stage there occurred any rise of IOP. While in Gp. I, there occurred an elevation of IOP only in those cases in which total laser energy was >60 mJ and it was also statistically not signifi cant. But when laser energy was <30 mJ, instead of rise, a fall in IOP was observed immediately after YAG capsulotomy (P < 0.001). This was in concurrence with the study by Khanzada et al. (2008) [14] where low energy levels used for laser capsulotomy lead to, IOP rise in only 3.1% cases in their study. It was explained by use of less total energy delivered leading to minimal production of prostaglandins, thereby not leading to post laser rise in IOP. Apart from the laser intervention, we found that duration between cataract surgery and PCO formation as well as grade of PCO has a signifi cant association with the amount of IOP rise. Similar associations have also been shown by Shaikh et al. (2010) . [15] Thus, the fi ndings of the present study help us to conclude that judicious control over laser energy delivery can infl uence the trend of IOP rise. Whenever anticipated that >60 mJ of energy is required as in higher grades of PCO and younger age, prophylactically Timolol maleate 0.5% eye drop should be instilled before Nd: YAG capsulotomy while all the other patients should just be kept under observation.
